Joe Stalder

Events by this organizer

june

22jun8:00 am9:00 amThe Shift from CRO to Sponsor: Building a Sponsor-focused PMO in an unfamiliar world8:00 am - 9:00 am

Event Details

Description

Name: The Shift from CRO to Sponsor: Building a Sponsor-focused PMO in an unfamiliar world
Start: 2023-6-22T08:00-7:00
End: 2023-6-22T09:00-7:00

Join us for an insightful and informative webinar as we explore the complexities and opportunities involved in transitioning from a Contract Research Organization (CRO) to becoming an independent drug developer (Sponsor). We will discuss some early learnings and the important role the PMO plays in an organization currently making this shift. By the end of this webinar, you’ll have a deeper understanding of the critical success factors and potential pitfalls associated with such significant transitions.

Objectives

Understand how an organization’s history creates its own barriers and opportunities
Ways to assess existing organizational capabilities and harnessing them
Hidden factors that influence resistance to new ideas and opportunities
The importance of speaking the same language – “Product” example
Building an R&D organization
The critical role a PMO plays in an organization’s transitions and establishing new ways of working

Speakers for this event

Jordan Lateiner

Jordan Lateiner
VP, Program Management at TrialSpark
Jordan Lateiner is an accomplished professional with over 20 years of experience in the pharmaceutical and biotechnology industry. Specializing in project and portfolio management, asset leadership, clinical development and operations, Jordan has a proven track record of successfully leading cross-functional teams and managing complex drug development programs from concept to market. For nearly 6 years he led the drug development efforts of Ubrelvy (ubrogepant) and Qulipta (atogepant) from Phase II through commercialization across Actavis, Allergan and AbbVie. Over a similar period he also served as Executive Director of Project Management at Allergan overseeing a large CNS drug portfolio and managing a team of exceptional Project Managers that drove multiple products into later stages of development. He joined TrialSpark in early 2022 as VP of Program Management as one of their first “R&D” hires to build out their transition from CRO to Sponsor.
Jordan holds a BS in Exercise Physiology from the University at Buffalo (SUNY), an MS in Neuroscience from Penn State University and an MBA in Healthcare Administration from Baruch College (CUNY)/Mt. Sinai School of Medicine. Jordan is also a certified Project Management Professional (PMP).
VP, Program Management at TrialSpark